Who founded Dyno Therapeutics?

Dyno Therapeutics was founded by Eric Kelsic, Sam Sinai, Adrian Veres, George Church, Tomas Bjorklund, Alan Crane in 2018.

Who are Dyno Therapeutics's investors?

Dyno Therapeutics's investors include Andreessen Horowitz, CRV (Charles River Ventures), GENERAL INCEPTION, GV (Google Ventures), Lux Capital, Obvious Ventures, Casdin Capital, KdT Ventures and 1 more.

Where is Dyno Therapeutics headquartered?

Dyno Therapeutics is headquartered in Watertown, US.

Dyno Therapeutics

Watertown, US · Founded 2018 · 95 employees on LinkedIn · 9 known investors

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.

AI & Machine Learning Biotech

Founders & leadership

Eric KelsicinCEO & Cofounder

Sam SinaiinVice President, Head of ML & Cofounder

Adrian VeresChief Scientific Officer & Cofounder

George ChurchScientific Cofounder

Tomas BjorklundScientific Co-founder

Alan CraneExecutive Chairman & Cofounder, Polaris Entrepreneur PartnerEntrepreneur Partner at Polaris Partners

Investors · 9

Andreessen HorowitzMenlo Park · $500K – $50M

CRV (Charles River Ventures)Bay Area · $250K – $5M

GENERAL INCEPTIONPalo Alto

GV (Google Ventures)Mountain View · $250K – $50M

Lux CapitalNew York · $100K – $100M

Obvious VenturesSan Francisco · $250K – $6M

Casdin CapitalreportedNew York

KdT Venturesreported · 2 sourcesAustin · $500K – $3M

Polaris PartnersreportedBoston · $500K – $5M

Competitors · 2

by search overlap

AskBio15 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

Danaher11 shared keywordsDanaher is a diversified conglomerate that operates a portfolio of businesses in life sciences, diagnostics, and related fields, guided by its Danaher Business System (DBS) operating model.

Companies competing with Dyno Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Dyno raises $100 million to bring artificial intelligence to gene therapy - The Boston Globebostonglobe.com · May 2021

Dyno Therapeutics Raises $100 Million to Accelerate AI‑powered Gene Therapy Platform - Global Genesglobalgenes.org · May 2021

Dyno Therapeutics Emerges with AI Platform and Two Deals to Improve Delivery of Gene Therapies - Global Genesglobalgenes.org · May 2020

Dyno Therapeutics Raises $9M in Seed Financing - FinSMEsfinsmes.com · May 2020

Frequently asked questions

What does Dyno Therapeutics do?: Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.
Who founded Dyno Therapeutics?: Dyno Therapeutics was founded by Eric Kelsic, Sam Sinai, Adrian Veres, George Church, Tomas Bjorklund, Alan Crane in 2018.
Who are Dyno Therapeutics's investors?: Dyno Therapeutics's investors include Andreessen Horowitz, CRV (Charles River Ventures), GENERAL INCEPTION, GV (Google Ventures), Lux Capital, Obvious Ventures, Casdin Capital, KdT Ventures and 1 more.
Where is Dyno Therapeutics headquartered?: Dyno Therapeutics is headquartered in Watertown, US.